Goldline Pharmaceutical Ltd. Press Release Jul 30 2026

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Prashant Shrikrishna Karkare

View Attachment